Cordis announced that it began the Radiancy pre-market clinical study of its vascular stent system for treating lesions in Europe.
Miami Lakes, Florida-based Cordis’ prospective, multi-center, single-arm study will assess the safety and efficacy of the S.M.A.R.T Radianz vascular stent system for the treatment of lesions in the iliac, superficial femoral or proximal popliteal arteries via radial artery access through 30-day follow-up.
According to a news release, Dr. Mercedes Guerra, the chief of angiology, vascular and endovascular surgery at the University Hospital of Guadalajara in Spain, performed the first procedure. That procedure was performed using the Brite Tip Radianz guiding sheath and the SaberX Radianz PTA balloon catheter to facilitate the delivery of the S.M.A.R.T Radianz self-expanding stent in an iliac lesion.
“My colleagues and I are pleased to have the opportunity to perform the first case in this significant clinical stud…